High-Risk Pregnancy: Maternal Comorbidity

  • Sanjay Datta
  • Bhavani Shankar Kodali
  • Scott Segal


Modern medicine has increased the longevity as well as the functional status of women who have systemic diseases. This has resulted in many women reaching childbearing age with successful pregnancies. In vitro fertilization has its own impact in this phenomenon. The end result is a steady increase in the number of women requiring high-risk obstetric and anesthetic care to successfully maneuver these individuals through pregnancy, labor, and delivery. This chapter will focus on pathophysiology of various comorbid conditions one might encounter during obstetric anesthetic practice, and how it influences the anesthetic management.


Human Immunodeficiency Virus Cesarean Section Cesarean Delivery Spinal Anesthesia Epidural Analgesia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Nylund L, Lunell NO, Lewander R, Persson B, Sarby B. Uteroplacental blood flow in diabetic pregnancy: measurements with indium 113 m and a computer-linked gamma camera. Am J Obstet Gynecol. 1982;144(3):298–302.PubMedGoogle Scholar
  2. 2.
    Madsen H, Ditzel J. Changes in red blood cell oxygen transport in diabetic pregnancy. Am J Obstet Gynecol. 1982;143(4):421–424.PubMedGoogle Scholar
  3. 3.
    Broulliard RG, Kitzmiller JL, Datta S. Buffering capacity and oxyhemoglobin affinity in infants of diabetic mothers. Anesthesiology. 1981;55:A318.Google Scholar
  4. 4.
    Di Mario U, Fallucca F, Gargiulo P, et al. Insulin–anti-insulin complexes in diabetic women and their neonates. Diabetologia. 1984;27(Suppl):83–86.CrossRefPubMedGoogle Scholar
  5. 5.
    Pearson JF. The effect of continuous lumbar epidural block on maternal and fetal acid–base balance during labor and at delivery. Proceedings of the Symposium on Epidural Analgesia in Obstetrics, London, 1972.Google Scholar
  6. 6.
    Shnider SM, Abboud TK, Artal R, Henriksen EH, Stefani SJ, Levinson G. Maternal catecholamines decrease during labor after lumbar epidural anesthesia. Am J Obstet Gynecol. 1983;147(1):13–15.PubMedGoogle Scholar
  7. 7.
    Datta S, Brown WU, Jr. Acid–base status in diabetic mothers and their infants following general or spinal anesthesia for cesarean section. Anesthesiology. 1977;47(3):272–276.CrossRefPubMedGoogle Scholar
  8. 8.
    Datta S, Brown WU, Jr., Ostheimer GW, Weiss JB, Alper MH. Epidural anesthesia for cesarean section in diabetic parturients: maternal and neonatal acid–base status and bupivacaine concentration. Anesth Analg. 1981;60(8):574–578.CrossRefPubMedGoogle Scholar
  9. 9.
    Milley JR, Rosenberg AA, Philipps AF, Molteni RA, Jones MD, Jr., Simmons MA. The effect of insulin on ovine fetal oxygen extraction. Am J Obstet Gynecol. 1984;149(6):673–678.PubMedGoogle Scholar
  10. 10.
    Datta S, Kitzmiller JL, Naulty JS, Ostheimer GW, Weiss JB. Acid–base status of diabetic mothers and their infants following spinal anesthesia for cesarean section. Anesth Analg. 1982;61(8):662–665.CrossRefPubMedGoogle Scholar
  11. 11.
    Lev-Ran A. Sharp temporary drop in insulin requirement after cesarean section in diabetic patients. Am J Obstet Gynecol. 1974;120(7):905–908.PubMedGoogle Scholar
  12. 12.
    Jones TW, Porter P, Sherwin RS, et al. Decreased epinephrine responses to hypoglycemia during sleep. N Engl J Med. 1998;338(23):1657–1662.CrossRefPubMedGoogle Scholar
  13. 13.
    Stonham J, Wakefield C. Phaeochromocytoma in pregnancy. Caesarean section under epidural analgesia. Anaesthesia. 1983;38(7):654–658.PubMedGoogle Scholar
  14. 14.
    Hudsmith JG, Thomas CE, Browne DA. Undiagnosed phaeochromocytoma mimicking severe preeclampsia in a pregnant woman at term. Int J Obstet Anesth. 2006;15(3):240–245.CrossRefPubMedGoogle Scholar
  15. 15.
    Takahashi K, Sai Y, Nosaka S. Anaesthetic management for caesarean section combined with removal of phaeochromocytoma. Eur J Anaesthesiol. 1998;15(3):364–366.PubMedGoogle Scholar
  16. 16.
    Garcia Hernandez E, Gonzalez Rodriguez JL, Vega Cruz MS. [Cesarean delivery and exeresis of a pheochromocytoma performed under epidural and general anesthesia]. Rev Esp Anestesiol Reanim. 2004;51(4):217–220.PubMedGoogle Scholar
  17. 17.
    Arendt KW, Connolly HM, Warnes CA, Watson WJ, Hebl JR, Craigo PA. Anesthetic management of parturients with congenitally corrected transposition of the great arteries: three cases and a review of the literature. Anesth Analg. 2008;107(6):1973–1977.CrossRefPubMedGoogle Scholar
  18. 18.
    Singh SI, Brooks C, Dobkowski W. General anesthesia using remifentanil for Cesarean delivery in a parturient with Marfan’s syndrome. Can J Anaesth. 2008;55(8):526–531.CrossRefPubMedGoogle Scholar
  19. 19.
    Bilehjani E, Kianfar AA, Toofan M, Fakhari S. Anesthesia with etomidate and remifentanil for cesarean section in a patient with severe peripartum cardiomyopathy – a case report. Middle East J Anesthesiol. 2008;19(5):1141–1149.PubMedGoogle Scholar
  20. 20.
    Ngan Kee WD, Khaw KS, Ma KC, Wong AS, Lee BB, Ng FF. Maternal and neonatal effects of remifentanil at induction of general anesthesia for cesarean delivery: a randomized, double-blind, controlled trial. Anesthesiology. 2006;104(1):14–20.CrossRefPubMedGoogle Scholar
  21. 21.
    Freund FG, Bonica JJ, Ward RJ, Akamatsu TJ, Kennedy WF, Jr.. Ventilatory reserve and level of motor block during high spinal and epidural anesthesia. Anesthesiology. 1967;28(5):834–837.CrossRefPubMedGoogle Scholar
  22. 22.
    Mallampati SR. Bronchospasm during spinal anesthesia. Anesth Analg. 1981;60(11):839–840.CrossRefPubMedGoogle Scholar
  23. 23.
    Yun E, Topulos GP, Body SC, Datta S, Bader AM. Pulmonary function changes during epidural anesthesia for cesarean delivery. Anesth Analg. 1996;82(4):750–753.CrossRefPubMedGoogle Scholar
  24. 24.
    Nathan RA, Segall N, Glover GC, Schocket AL. The effects of H1 and H2 antihistamines on histamine inhalation challenges in asthmatic patients. Am Rev Respir Dis. 1979;120(6):1251–1258.PubMedGoogle Scholar
  25. 25.
    Baraka A. Epidural meperidine for control of autonomic hyperreflexia in a paraplegic parturient. Anesthesiology. 1985;62(5):688–690.CrossRefPubMedGoogle Scholar
  26. 26.
    Confavreux C, Hutchinson M, Hours MM, Cortinovis-Tourniaire P, Moreau T. Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group. N Engl J Med. 1998;339(5):285–291.CrossRefPubMedGoogle Scholar
  27. 27.
    Bader AM, Hunt CO, Datta S, Naulty JS, Ostheimer GW. Anesthesia for the obstetric patient with multiple sclerosis. J Clin Anesth. 1988;1(1):21–24.CrossRefPubMedGoogle Scholar
  28. 28.
    Newman B, Gelb AW, Lam AM. The effect of isoflurane-induced hypotension on cerebral blood flow and cerebral metabolic rate for oxygen in humans. Anesthesiology. 1986;64(3):307–310.CrossRefPubMedGoogle Scholar
  29. 29.
    Cohen BA, London RS, Goldstein PJ. Myasthenia gravis and preeclampsia. Obstet Gynecol. 1976;48(1 Suppl):35S–37S.PubMedGoogle Scholar
  30. 30.
    Rolbin WH, Levinson G, Shnider SM, Wright RG. Anesthetic considerations for myasthenia gravis and pregnancy. Anesth Analg. 1978;57(4):441–447.CrossRefPubMedGoogle Scholar
  31. 31.
    Terblanche N, Maxwell C, Keunen J, Carvalho JC. Obstetric and anesthetic management of severe congenital myasthenia syndrome. Anesth Analg. 2008;107(4):1313–1315.CrossRefPubMedGoogle Scholar
  32. 32.
    Kalidindi M, Ganpot S, Tahmesebi F, Govind A, Okolo S, Yoong W. Myasthenia gravis and pregnancy. J Obstet Gynaecol. 2007;27(1):30–32.CrossRefPubMedGoogle Scholar
  33. 33.
    Usubiaga JE, Wikinski JA, Morales RL, Usubiaga LE. Interaction of intravenously administered procaine, lidocaine and succinylcholine in anesthetized subjects. Anesth Analg. 1967;46(1):39–45.CrossRefPubMedGoogle Scholar
  34. 34.
    Hepner DL, Wilkins-Haug L, Marks PW. Hematologic disease. In: Datta S, ed. Anesthetic and Obstetric Management of High-Risk Pregnancy. 3rd ed. New York: Springer; 2003:309–332.Google Scholar
  35. 35.
    Sage DJ. Epidurals, spinals and bleeding disorders in pregnancy: a review. Anaesth Intensive Care. 1990;18(3):319–326.PubMedGoogle Scholar
  36. 36.
    Meinardi JR, Middeldorp S, de Kam PJ, et al. Increased risk for fetal loss in carriers of the factor V Leiden mutation. Ann Intern Med. 1999;130(9):736–739.PubMedGoogle Scholar
  37. 37.
    Harnett MJ, Walsh ME, McElrath TF, Tsen LC. The use of central neuraxial techniques in parturients with factor V leiden mutation. Anesth Analg. 2005;101(6):1821–1823.CrossRefPubMedGoogle Scholar
  38. 38.
    Horlocker TT, Wedel DJ. Neuraxial block and low-molecular-weight heparin: balancing perioperative analgesia and thromboprophylaxis. Reg Anesth Pain Med. 1998;23(6 Suppl 2):164–177.PubMedGoogle Scholar
  39. 39.
    Aguilar D, Goldhaber SZ. Clinical uses of low-molecular-weight heparins. Chest. 1999;115(5):1418–1423.CrossRefPubMedGoogle Scholar
  40. 40.
    Hague WM, North RA, Gallus AS, et al. Anticoagulation in pregnancy and the puerperium. Med J Aust. 2001;175(5):258–263.PubMedGoogle Scholar
  41. 41.
    Keenan MA, Stiles CM, Kaufman RL. Acquired laryngeal deviation associated with cervical spine disease in erosive polyarticular arthritis. Use of the fiberoptic bronchoscope in rheumatoid disease. Anesthesiology. 1983;58(5):441–449.CrossRefPubMedGoogle Scholar
  42. 42.
    Mecacci F, Bianchi B, Pieralli A, et al. Pregnancy outcome in systemic lupus erythematosus complicated by anti-phospholipid antibodies. Rheumatology (Oxford). 2008.Google Scholar
  43. 43.
    Stepankova J, Burgelova M, Honsova E, Tesar V, Vrbska J, Viklicky O. Preeclampsia, dilated cardiomyopathy and renal failure as the first manifestation of systemic lupus erythematosus: a case report. Clin Rheumatol. 2008.Google Scholar
  44. 44.
    Malinow AM, Rickford WJ, Mokriski BL, Saller DN, McGuinn WJ: Lupus anticoagulant. Implications for obstetric anaesthetists. Anaesthesia. 1987;42(12):1291–1293.CrossRefPubMedGoogle Scholar
  45. 45.
    Harnett M, Kodali BS. Thromboelastography assessment of coagulation status in parturients with lupus anticoagulant receiving heparin therapy. Int J Obstet Anesth. 2006;15(2):177–178.CrossRefPubMedGoogle Scholar
  46. 46.
    Cregler LL, Mark H. Medical complications of cocaine abuse. N Engl J Med. 1986;315(23):1495–1500.CrossRefPubMedGoogle Scholar
  47. 47.
    Acker D, Sachs BP, Tracey KJ, Wise WE. Abruptio placentae associated with cocaine use. Am J Obstet Gynecol. 1983;146(2):220–221.PubMedGoogle Scholar
  48. 48.
    Bader AM, Camann WR, Datta S. Anesthesia for cesarean delivery in patients with herpes simplex virus type-2 infections. Reg Anesth. 1990;15(5):261–263.PubMedGoogle Scholar
  49. 49.
    Evron S, Glezerman M, Harow E, Sadan O, Ezri T. Human immunodeficiency virus: anesthetic and obstetric considerations. Anesth Analg. 2004;98(2):503–511.CrossRefPubMedGoogle Scholar
  50. 50.
    Ho DD, Rota TR, Schooley RT, et al. Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome. N Engl J Med. 1985;313(24):1493–1497.CrossRefPubMedGoogle Scholar
  51. 51.
    Barzan L, Carbone A, Saracchini S, Vaccher G, Tirelli U, Comoretto R. Nasopharyngeal lymphatic tissue hypertrophy in HIV-infected patients. Lancet. 1989;1(8628):42–43.CrossRefPubMedGoogle Scholar
  52. 52.
    Davies JM, Thistlewood JM, Rolbin SH, Douglas MJ. Infections and the parturient: anaesthetic considerations. Can J Anaesth. 1988;35(3 Pt 1):270–277.CrossRefPubMedGoogle Scholar
  53. 53.
    Maccani RM, Wedel DJ, Hofer RE. Norepinephrine does not potentiate porcine malignant hyperthermia. Anesth Analg. 1996;82(4):790–795.CrossRefPubMedGoogle Scholar
  54. 54.
    Harter RL, Kelly WB, Kramer MG, Perez CE, Dzwonczyk RR. A comparison of the volume and pH of gastric contents of obese and lean surgical patients. Anesth Analg. 1998;86(1):147–152.CrossRefPubMedGoogle Scholar
  55. 55.
    Hood DD, Dewan DM. Anesthetic and obstetric outcome in morbidly obese parturients. Anesthesiology. 1993;79(6):1210–1218.CrossRefPubMedGoogle Scholar
  56. 56.
    Mhyre JM, Riesner MN, Polley LS, Naughton NN. A series of anesthesia-related maternal deaths in Michigan, 1985–2003. Anesthesiology. 2007;106(6):1096–1104.CrossRefPubMedGoogle Scholar
  57. 57.
    Mhyre JM. Anesthetic management for the morbidly obese pregnant woman. Int Anesthesiol Clin. 2007;45(1):51–70.CrossRefPubMedGoogle Scholar
  58. 58.
    Kodali BS, Lee-Parritz A. The morbidly obese pregnant woman. In: Datta S, ed. Anesthetic and Obstetric Management of High-Risk Pregnancy. New York: Springer; 2003:53–66.Google Scholar
  59. 59.
    Pian-Smith MCM, Datta S, Greene MF. The diabetic parturient. In: Datta S, ed. Anesthetic and Obstetric Management of High Risk Pregnancy, 3rd ed. New York: Springer; 2004.Google Scholar
  60. 60.
    Datta S, ed. Anesthetic and Obstetric Management of High Risk Pregnancy. 2nd ed. St Louis: Mosby; 1996.Google Scholar
  61. 61.
    Hirshman CA, Downes H, Farbood A, et al. Ketamine block of bronchospasm in experimental canine asthma. Br J Anaesth. 1979;51:713–717.CrossRefPubMedGoogle Scholar
  62. 62.
    Abouleish EI, Hanley ES, Palmer SM. Can epidural Fentanyl control automatic hyperreflexia in a quadriplegic parturient? Anesth Analg. 1989;68:523–526.CrossRefPubMedGoogle Scholar
  63. 63.
    Sharma SK, Leveno KJ. Anticoagulated patient. In: Datta S, ed. Anesthetic and Obstetric Management of High-Risk Pregnancy. 3rd ed. New York: Springer; 2004.Google Scholar
  64. 64.
    Longmire S, Lee W, Pivarnik J. Malignant hyperthermia. In: Datta S, ed. Anesthetic and Obstetric Management of High Risk Pregnancy. Chicago: Mosby-Year Book; 1991:337.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Sanjay Datta
    • 1
    • 2
  • Bhavani Shankar Kodali
    • 1
    • 2
  • Scott Segal
    • 1
    • 2
  1. 1.Brigham & Women’s HospitalBostonUSA
  2. 2.Harvard Medical SchoolBostonUSA

Personalised recommendations